CME Group Stock-Based Compensation 2010-2025 | CME

CME Group stock-based compensation for the twelve months ending June 30, 2025 was $215M, a 3.91% increase year-over-year.

  • CME Group annual stock-based compensation for 2024 was $0.09B, a 7.96% increase from 2023.
  • CME Group annual stock-based compensation for 2023 was $0.083B, a 1.66% decline from 2022.
  • CME Group annual stock-based compensation for 2022 was $0.084B, a 12.1% increase from 2021.

CME Group Stock-Based Compensation 2010-2025 | CME

  • CME Group annual stock-based compensation for 2024 was $0.09B, a 7.96% increase from 2023.
  • CME Group annual stock-based compensation for 2023 was $0.083B, a 1.66% decline from 2022.
  • CME Group annual stock-based compensation for 2022 was $0.084B, a 12.1% increase from 2021.
Related Stocks
Company NameMarket
Cap
S&P Global (SPGI)$169.9B
Intercontinental Exchange (ICE)$103.7B
London Stock Exchange Group - (LNSTY)$67.4B
Deutsche Boerse AG (DBOEY)$56.4B
Nasdaq (NDAQ)$54.3B
OTC Markets Group (OTCM)$661M